TY  - GEN
AU  - Voest,E E
AU  - Neijt,J P
AU  - Keunen,J E
AU  - Dekker,A W
AU  - van Asbeck,B S
AU  - Nortier,J W
AU  - Ros,F E
AU  - Marx,J J
TI  - Phase I study using desferrioxamine and iron sorbitol citrate in an attempt to modulate the iron status of tumor cells to enhance doxorubicin activity
SN  - 0344-5704
PY  - 1993///0317
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Citrates
KW  - administration & dosage
KW  - Citric Acid
KW  - Deferoxamine
KW  - Dose-Response Relationship, Drug
KW  - Doxorubicin
KW  - Drug Combinations
KW  - Drug Synergism
KW  - Eye
KW  - drug effects
KW  - Female
KW  - Ferric Compounds
KW  - Humans
KW  - Iron
KW  - pharmacokinetics
KW  - Lymphoma, Non-Hodgkin
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Neoplasms
KW  - Sorbitol
KW  - Tumor Cells, Cultured
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article
UR  - https://doi.org/10.1007/BF00686148
ER  -